Evidence map›Paper›PMID 27826170›Full record

ReviewReumatologia

Rheumatic diseases induced by drugs and environmental factors: the state-of-the-art - part two.

Karolina Niklas, Arkadiusz A Niklas, Dominik Majewski, Mariusz J Puszczewicz

Abstract readReview
In one paragraph

Review in Reumatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Biomarkers in connective tissue diseases.The Journal of allergy and clinical immunology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Karolina NiklasDepartment of Rheumatology and Internal Diseases, Poznan University of Medical Science, Poland.
Arkadiusz A NiklasDepartment of Hypertension, Angiology and Internal Medicine, Poznan University of Medical Science, Poland.
Dominik MajewskiDepartment of Rheumatology and Internal Diseases, Poznan University of Medical Science, Poland.
Mariusz J PuszczewiczDepartment of Rheumatology and Internal Diseases, Poznan University of Medical Science, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The majority of rheumatic diseases belong to the group of autoimmune diseases and are associated with autoantibody production. Their etiology is not fully understood. Certain medications and environmental factors may have an influence on the occurrence of rheumatic diseases. Establishing a cause-effect relationship between a certain factor and disease induction is not always simple. It is important to administer the drug continuously or monitor exposure to a given factor in the period preceding the onset of symptoms. The lack of early diagnosed autoimmune disease, or finally the lack of symptoms within a few weeks/months after discontinuation of the drug/cessation of exposure, is also important. The most frequently mentioned rheumatic diseases caused by drugs and environmental factors include systemic lupus erythematosus (SLE), scleroderma, systemic vasculitis, polymyositis, dermatomyositis, and Sjögren's syndrome. The objective of this study is to summarize current knowledge on rheumatic diseases induced by drugs and environmental factors.

Indexed as

drugsenvironmental factorsrheumatic diseases

Identifiers

PMID27826170
PMCPMC5090024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.